Covered recipient · General Payments record
ANDREW S COLE
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$1,804.17
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $711.26 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $344.07 | 18 |
| Nevro Corp. | $171.83 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.08 | 2 |
| Otsuka America Pharmaceutical, Inc. | $29.52 | 1 |
| Novo Nordisk AS | $29.37 | 2 |
| Indivior Inc. | $23.18 | 1 |
| Alkermes, Inc. | $17.76 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.11 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489085 | CMS |
| ABBVIE INC. | $16.99 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489087 | CMS |
| ABBVIE INC. | $7.35 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489089 | CMS |
| ABBVIE INC. | $8.58 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489091 | CMS |
| ABBVIE INC. | $1.96 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489093 | CMS |
| ABBVIE INC. | $29.17 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489095 | CMS |
| ABBVIE INC. | $16.68 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489097 | CMS |
| ABBVIE INC. | $125.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489099 | CMS |
| ABBVIE INC. | $9.17 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489101 | CMS |
| ABBVIE INC. | $23.12 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489103 | CMS |
| ABBVIE INC. | $10.93 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489105 | CMS |
| ABBVIE INC. | $4.55 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489107 | CMS |
| ABBVIE INC. | $6.85 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489109 | CMS |
| ABBVIE INC. | $20.11 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489111 | CMS |
| ABBVIE INC. | $24.04 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489113 | CMS |
| ABBVIE INC. | $18.33 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489115 | CMS |
| ABBVIE INC. | $9.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489117 | CMS |
| ABBVIE INC. | $3.93 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103489119 | CMS |
| Alkermes, Inc. | $17.76 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120481774 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $62.38 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118117228 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118117226 | CMS |
| Indivior Inc. | $23.18 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144526038 | CMS |
| Nevro Corp. | $43.66 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130774051 | CMS |
| Nevro Corp. | $128.17 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130774053 | CMS |
| Novo Nordisk Inc | $14.99 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097773244 | CMS |
| Novo Nordisk Inc | $14.38 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097125196 | CMS |
| Otsuka America Pharmaceutical, Inc. | $29.52 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118878050 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.45 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105911104 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.